Declining Incidence Rates of Distal Symmetric Polyneuropathy in People With Type 1 and Type 2 Diabetes in Denmark, With Indications of Distinct Patterns in Type 1 Diabetes

被引:6
作者
Mizrak, Hatice Isik [1 ]
Hansen, Tine Willum [1 ]
Rossing, Peter [1 ,2 ]
Curovic, Viktor Rotbain [1 ]
Vistisen, Dorte [1 ,2 ]
Amadid, Hanan [1 ]
Hansen, Christian Stevns [1 ]
机构
[1] Steno Diabet Ctr Copenhagen, Herlev, Denmark
[2] Univ Copenhagen, Dept Clin Med, Copenhagen, Denmark
关键词
PERIPHERAL SENSORY NEUROPATHY; RISK-FACTORS; PREVALENCE; COMPLICATIONS; THRESHOLDS; THERAPY; IMPACT;
D O I
10.2337/dc23-0312
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
<bold>Objective: </bold>It is not known if incidence rates for diabetic distal symmetric polyneuropathy (DSPN) are decreasing, as they are for other diabetic complications. Here, we investigated incidence rates of DSPN in type 1 and type 2 diabetes in a large population-based study. <bold>Research design and methods: </bold>In the period 1996 to 2018, 19,342 individuals were identified at a Danish tertiary diabetes center. Vibration perception threshold was assessed by biothesiometry and repeated throughout the study. Exclusion of prevalent DSPN cases or missing data left data on 9,473 individuals for analysis of DSPN using a cutoff of >25 V and on 2,783 individuals for analysis using an age-, sex-, and height-specific cutoff. Poisson regression analysis was used to model incidence rates of DSPN for both cutoff types and separately for diabetes types. Covariates were sex, age, diabetes duration, and calendar time. <bold>Results: </bold>Incidence rates (95% CI) of DSPN decreased from 1996 to 2018 (e.g., from 4.78 [3.60-6.33]/100 person-years [PY] to 1.15 [0.91-1.47]/100 PY for 40-year-old men with type 1 diabetes and from 16.54 [11.80-23.18]/100 PY to 8.02 [6.63-9.69]/100 PY for 60-year-old men with type 2 diabetes, when using >25 V as the cutoff value). Analyses using age-, sex-, and height-specific cutoff values demonstrated similar incidence patterns by calendar time without sex differences. For type 1 diabetes, decreasing incidence rates were seen with older age. <bold>Conclusions: </bold>Incidence rates for DSPN are declining in type 1 and type 2 diabetes, possibly due to improved diabetes treatment. This causality remains to be explored. Distinct age-related patterns indicate that the pathophysiology of DSPN may differ between diabetes types.
引用
收藏
页码:1997 / 2003
页数:8
相关论文
共 38 条
  • [1] Risk factors for diabetic peripheral sensory neuropathy - Results of the Seattle Prospective Diabetic Foot Study
    Adler, AI
    Boyko, EJ
    Ahroni, JH
    Stensel, V
    Forsberg, RC
    Smith, DG
    [J]. DIABETES CARE, 1997, 20 (07) : 1162 - 1167
  • [2] Time trends of cardiovascular risk management in type 1 diabetes - nationwide analyses of real-life data
    Amadid, Hanan
    Clemmensen, Kim Katrine Bjerring
    Vistisen, Dorte
    Persson, Frederik
    Jorgensen, Marit Eika
    [J]. CARDIOVASCULAR DIABETOLOGY, 2022, 21 (01)
  • [3] Glucose Control and Diabetic Neuropathy: Lessons from Recent Large Clinical Trials
    Ang, Lynn
    Jaiswal, Mamta
    Martin, Catherine
    Pop-Busui, Rodica
    [J]. CURRENT DIABETES REPORTS, 2014, 14 (09) : 1 - 15
  • [4] USE OF A BIOTHESIOMETER TO MEASURE INDIVIDUAL VIBRATION THRESHOLDS AND THEIR VARIATION IN 519 NON-DIABETIC SUBJECTS
    BLOOM, S
    TILL, S
    SONKSEN, P
    SMITH, S
    [J]. BRITISH MEDICAL JOURNAL, 1984, 288 (6433) : 1793 - 1795
  • [5] Enhanced glucose control for preventing and treating diabetic neuropathy
    Callaghan, B. C.
    Little, A. A.
    Feldman, E. L.
    Hughes, R. A. C.
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2012, (06):
  • [6] Impact of early detection and treatment of diabetes on the 6-year prevalence of cardiac autonomic neuropathy in people with screen-detected diabetes: ADDITION-Denmark, a cluster-randomised study
    Charles, M.
    Fleischer, J.
    Witte, D. R.
    Ejskjaer, N.
    Borch-Johnsen, K.
    Lauritzen, T.
    Sandbaek, A.
    [J]. DIABETOLOGIA, 2013, 56 (01) : 101 - 108
  • [7] Prevalence of Neuropathy and Peripheral Arterial Disease and the Impact of Treatment in People With Screen-Detected Type 2 Diabetes
    Charles, Morten
    Ejskjaer, Niels
    Witte, Daniel R.
    Borch-Johnsen, Knut
    Lauritzen, Torsten
    Sandbaek, Annelli
    [J]. DIABETES CARE, 2011, 34 (10) : 2244 - 2249
  • [8] Lipid-lowering therapy and peripheral sensory neuropathy in type 2 diabetes: the Fremantle Diabetes Study
    Davis, T. M. E.
    Yeap, B. B.
    Davis, W. A.
    Bruce, D. G.
    [J]. DIABETOLOGIA, 2008, 51 (04) : 562 - 566
  • [9] Glucose Control and Vascular Complications in Veterans with Type 2 Diabetes
    Duckworth, William
    Abraira, Carlos
    Moritz, Thomas
    Reda, Domenic
    Emanuele, Nicholas
    Reaven, Peter D.
    Zieve, Franklin J.
    Marks, Jennifer
    Davis, Stephen N.
    Hayward, Rodney
    Warren, Stuart R.
    Goldman, Steven
    McCarren, Madeline
    Vitek, Mary Ellen
    Henderson, William G.
    Huang, Grant D.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (02) : 129 - U62
  • [10] Hypertension as a risk factor for diabetic neuropathy - A prospective study
    Forrest, KYZ
    Maser, RE
    Pambianco, G
    Becker, DJ
    Orchard, TJ
    [J]. DIABETES, 1997, 46 (04) : 665 - 670